Top View
- Kent Academic Repository Full Text Document (Pdf)
- Mark J. Suto, Ph.D. Drug Discovery Division Southern Research
- The Efficacy of the Calcium Channel Antagonist Mibefradil
- A A-1048400, 41–42 Absence Epilepsy Definition, 95 Genetics Of, 101–103 Low-Voltage Threshold Antiseizure Drugs, 101 Cacna1a
- Modulation of Subthalamic T-Type Ca2+ Channels Remedies Locomotor
- Zonisamide Can Ameliorate the Voltage-Dependence Alteration of the T-Type Calcium Channel Ca
- Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
- KENTUCKY HORSE RACING Chapter: \810\008.020REG
- Drug Interactions of Medications Commonly Used in Diabetes
- Voltage-Gated N-Type and T-Type Calcium Channels and Excitability Disorders
- Supplemental Table 1 V2
- Antidepressant–Drug Interactions Are Potentially but Rarely Clinically Significant
- The Effects of Flufenamic Acid on Spontaneous Activity of Smooth Muscle Tissue Isolated from the Guinea-Pig Stomach Antrum
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- University of Dundee the CONCISE GUIDE to PHARMACOLOGY 2017/18 Alexander, Stephen P. H.; Kelly, Eamonn; Marrion, Neil V.; Peters
- Creation of a New Class of Radiosensitizers for Glioblastoma Based on the Mibefradil Pharmacophore
- Effects of Mibefradil, a Novel Calcium Channel Blocking Agent with T-Type
- Study Protocol
- Drug-Induced Mitochondrial Dysfunction: an Emerging Model for Idiosyncratic Drug Toxicity
- REVIEW Molecular Pharmacology of T-Type Ca2+ Channels
- In Search of a Breakthrough Therapy for Glioblastoma Multiforme
- AERC Drug Rule Appendices
- Ethanol 40 L-Glutamic Acid 39 Zonisamide 30 Picrotoxin 22
- TOHUTUTIMULERUNTUS009750747B2 (12 ) United States Patent ( 10 ) Patent No
- The Addition of Mibefradil to Chronic Hydrochlorothiazide Therapy in Hypertensive Patients Is Associated with a Significant Antihypertensive Effect
- ADAP Quarterly NDC Special Review
- Mark J. Suto, Ph.D. Drug Discovery Division Southern Research [email protected] Targets Validation